Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study
- 22 February 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 128 (1), 75-84
- https://doi.org/10.1007/s11060-016-2078-0
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Tacrolimus‐associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantationAmerican Journal of Hematology, 2013
- Chemotherapy-related posterior reversible leukoencephalopathy syndromeNature Reviews Neurology, 2009
- Cisplatin-induced non-convulsive posterior reversible encephalopathy syndrome in a 41-year-old woman with metastatic malignant melanomaRadiology and Oncology, 2009
- A Case of Gemcitabine and Cisplatin Associated Posterior Reversible Encephalopathy SyndromeCancer Research and Treatment, 2009
- Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic EdemaAmerican Journal Of Neuroradiology, 2008
- Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical FeaturesAmerican Journal Of Neuroradiology, 2008
- Gemcitabine-Induced Reversible Posterior Leukoencephalopathy Syndrome: A Case Report and Review of the LiteratureThe Oncologist, 2007
- Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndromeAnnals of Oncology, 2007
- Distinct Imaging Patterns and Lesion Distribution in Posterior Reversible Encephalopathy SyndromeAmerican Journal Of Neuroradiology, 2007
- Mechanisms of adverse effects of anti-VEGF therapy for cancerBritish Journal of Cancer, 2007